American Assets Investment Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
American Assets Investment Management's BIIB Position: Q4 2024 in Review
American Assets Investment Management sold out of Biogen (BIIB) in Q4 2024, closing a stake of 20,000 shares — an estimated $3.88M sold.
American Assets Investment Management first reported a position in BIIB in Q1 2017 and held it in 27 quarters. The position peaked at $5.7M in Q2 2023. 875 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.
- American Assets Investment Management reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
- American Assets Investment Management sold 20,000 Biogen shares in Q4 2024, an estimated $3.88M.
- American Assets Investment Management first reported a position in Biogen in Q1 2017 and held it in 27 quarters.
- American Assets Investment Management's Biogen position peaked at $5.7M in Q2 2023.
- 875 funds tracked by Wall St. Rank held Biogen as of Q4 2024.
Based on American Assets Investment Management's 13F filing for Q4 2024, filed 10 Feb 2025.